Selected research
Industry Research
Targeted NGS Amplicon Sequencing Services Industry Research Report 2026
Market perspective
The global Targeted NGS Amplicon Sequencing Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Targeted NGS Amplicon Sequencing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Targeted NGS Amplicon Sequencing Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Targeted NGS Amplicon Sequencing Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Targeted NGS Amplicon Sequencing Services include Novogene, BGI (BGI Genomics), Macrogen, Psomagen, SeqMatic, CD Genomics, AllGenetics, Charles River and Source BioScience, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Targeted NGS Amplicon Sequencing Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Targeted NGS Amplicon Sequencing Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Targeted NGS Amplicon Sequencing Services Market by Company
Novogene
BGI (BGI Genomics)
Macrogen
Psomagen
SeqMatic
CD Genomics
AllGenetics
Charles River
Source BioScience
AGRF
Plasmidsaurus
Eurofins Scientific
Charles River Laboratories
ABM
Zymo Research
Paragon Genomics
Quintara Bio
HyLabs
MUGTC
SeqCoast Genomics
Shanghai Baiqu Biomedical Technology
Illumina
Guangzhou IGE Biotechnology
IDT
Azenta Life Sciences
Eurofins Genomics
Targeted NGS Amplicon Sequencing Services Segment by Type
Single-Gene Sequencing
Multi-Gene Panel Sequencing
Customized Region Sequencing
Targeted NGS Amplicon Sequencing Services Segment by Application
Clinical Molecular Diagnostics
Human Genetics & Population Research
Agricultural Biotechnology & Breeding
Industrial Biotechnology
Others
Targeted NGS Amplicon Sequencing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted NGS Amplicon Sequencing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Targeted NGS Amplicon Sequencing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted NGS Amplicon Sequencing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Targeted NGS Amplicon Sequencing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-Gene Sequencing
- Multi-Gene Panel Sequencing
- Customized Region Sequencing
Applications
- Clinical Molecular Diagnostics
- Human Genetics & Population Research
- Agricultural Biotechnology & Breeding
- Industrial Biotechnology
- Others
Companies covered
- Novogene
- BGI (BGI Genomics)
- Macrogen
- Psomagen
- SeqMatic
- CD Genomics
- AllGenetics
- Charles River
- Source BioScience
- AGRF
- Plasmidsaurus
- Eurofins Scientific
- Charles River Laboratories
- ABM
- Zymo Research
- Paragon Genomics
- Quintara Bio
- HyLabs
- MUGTC
- SeqCoast Genomics
- Shanghai Baiqu Biomedical Technology
- Illumina
- Guangzhou IGE Biotechnology
- IDT
- Azenta Life Sciences
- Eurofins Genomics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Targeted NGS Amplicon Sequencing Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Single-Gene Sequencing
- 2.2.3 Multi-Gene Panel Sequencing
- 2.2.4 Customized Region Sequencing
- 2.3 Targeted NGS Amplicon Sequencing Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Molecular Diagnostics
- 2.3.3 Human Genetics & Population Research
- 2.3.4 Agricultural Biotechnology & Breeding
- 2.3.5 Industrial Biotechnology
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Targeted NGS Amplicon Sequencing Services Breakdown Data by Type
- 3.1 Global Targeted NGS Amplicon Sequencing Services Historic Market Size by Type (2021-2026)
- 3.2 Global Targeted NGS Amplicon Sequencing Services Forecasted Market Size by Type (2027-2032)
4 Targeted NGS Amplicon Sequencing Services Breakdown Data by Application
- 4.1 Global Targeted NGS Amplicon Sequencing Services Historic Market Size by Application (2021-2026)
- 4.2 Global Targeted NGS Amplicon Sequencing Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Targeted NGS Amplicon Sequencing Services Market Perspective (2021-2032)
- 5.2 Global Targeted NGS Amplicon Sequencing Services Growth Trends by Region
- 5.2.1 Global Targeted NGS Amplicon Sequencing Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Targeted NGS Amplicon Sequencing Services Historic Market Size by Region (2021-2026)
- 5.2.3 Targeted NGS Amplicon Sequencing Services Forecasted Market Size by Region (2027-2032)
- 5.3 Targeted NGS Amplicon Sequencing Services Market Dynamics
- 5.3.1 Targeted NGS Amplicon Sequencing Services Industry Trends
- 5.3.2 Targeted NGS Amplicon Sequencing Services Market Drivers
- 5.3.3 Targeted NGS Amplicon Sequencing Services Market Challenges
- 5.3.4 Targeted NGS Amplicon Sequencing Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Targeted NGS Amplicon Sequencing Services Players by Revenue
- 6.1.1 Global Top Targeted NGS Amplicon Sequencing Services Players by Revenue (2021-2026)
- 6.1.2 Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Targeted NGS Amplicon Sequencing Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Targeted NGS Amplicon Sequencing Services Head Office and Area Served
- 6.4 Global Targeted NGS Amplicon Sequencing Services Players, Product Type & Application
- 6.5 Global Targeted NGS Amplicon Sequencing Services Manufacturers Established Date
- 6.6 Global Targeted NGS Amplicon Sequencing Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Targeted NGS Amplicon Sequencing Services Market Size (2021-2032)
- 7.2 North America Targeted NGS Amplicon Sequencing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Targeted NGS Amplicon Sequencing Services Market Size by Country (2021-2026)
- 7.4 North America Targeted NGS Amplicon Sequencing Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Targeted NGS Amplicon Sequencing Services Market Size (2021-2032)
- 8.2 Europe Targeted NGS Amplicon Sequencing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Targeted NGS Amplicon Sequencing Services Market Size by Country (2021-2026)
- 8.4 Europe Targeted NGS Amplicon Sequencing Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size (2021-2032)
- 9.2 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Targeted NGS Amplicon Sequencing Services Market Size (2021-2032)
- 10.2 South America Targeted NGS Amplicon Sequencing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Targeted NGS Amplicon Sequencing Services Market Size by Country (2021-2026)
- 10.4 South America Targeted NGS Amplicon Sequencing Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size (2021-2032)
- 11.2 Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Novogene
- 12.1.1 Novogene Company Information
- 12.1.2 Novogene Business Overview
- 12.1.3 Novogene Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.1.4 Novogene Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.1.5 Novogene Recent Developments
- 12.2 BGI (BGI Genomics)
- 12.2.1 BGI (BGI Genomics) Company Information
- 12.2.2 BGI (BGI Genomics) Business Overview
- 12.2.3 BGI (BGI Genomics) Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.2.4 BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.2.5 BGI (BGI Genomics) Recent Developments
- 12.3 Macrogen
- 12.3.1 Macrogen Company Information
- 12.3.2 Macrogen Business Overview
- 12.3.3 Macrogen Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.3.4 Macrogen Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.3.5 Macrogen Recent Developments
- 12.4 Psomagen
- 12.4.1 Psomagen Company Information
- 12.4.2 Psomagen Business Overview
- 12.4.3 Psomagen Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.4.4 Psomagen Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.4.5 Psomagen Recent Developments
- 12.5 SeqMatic
- 12.5.1 SeqMatic Company Information
- 12.5.2 SeqMatic Business Overview
- 12.5.3 SeqMatic Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.5.4 SeqMatic Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.5.5 SeqMatic Recent Developments
- 12.6 CD Genomics
- 12.6.1 CD Genomics Company Information
- 12.6.2 CD Genomics Business Overview
- 12.6.3 CD Genomics Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.6.4 CD Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.6.5 CD Genomics Recent Developments
- 12.7 AllGenetics
- 12.7.1 AllGenetics Company Information
- 12.7.2 AllGenetics Business Overview
- 12.7.3 AllGenetics Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.7.4 AllGenetics Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.7.5 AllGenetics Recent Developments
- 12.8 Charles River
- 12.8.1 Charles River Company Information
- 12.8.2 Charles River Business Overview
- 12.8.3 Charles River Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.8.4 Charles River Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.8.5 Charles River Recent Developments
- 12.9 Source BioScience
- 12.9.1 Source BioScience Company Information
- 12.9.2 Source BioScience Business Overview
- 12.9.3 Source BioScience Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.9.4 Source BioScience Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.9.5 Source BioScience Recent Developments
- 12.10 AGRF
- 12.10.1 AGRF Company Information
- 12.10.2 AGRF Business Overview
- 12.10.3 AGRF Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.10.4 AGRF Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.10.5 AGRF Recent Developments
- 12.11 Plasmidsaurus
- 12.11.1 Plasmidsaurus Company Information
- 12.11.2 Plasmidsaurus Business Overview
- 12.11.3 Plasmidsaurus Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.11.4 Plasmidsaurus Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.11.5 Plasmidsaurus Recent Developments
- 12.12 Eurofins Scientific
- 12.12.1 Eurofins Scientific Company Information
- 12.12.2 Eurofins Scientific Business Overview
- 12.12.3 Eurofins Scientific Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.12.4 Eurofins Scientific Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.12.5 Eurofins Scientific Recent Developments
- 12.13 Charles River Laboratories
- 12.13.1 Charles River Laboratories Company Information
- 12.13.2 Charles River Laboratories Business Overview
- 12.13.3 Charles River Laboratories Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.13.4 Charles River Laboratories Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.13.5 Charles River Laboratories Recent Developments
- 12.14 ABM
- 12.14.1 ABM Company Information
- 12.14.2 ABM Business Overview
- 12.14.3 ABM Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.14.4 ABM Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.14.5 ABM Recent Developments
- 12.15 Zymo Research
- 12.15.1 Zymo Research Company Information
- 12.15.2 Zymo Research Business Overview
- 12.15.3 Zymo Research Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.15.4 Zymo Research Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.15.5 Zymo Research Recent Developments
- 12.16 Paragon Genomics
- 12.16.1 Paragon Genomics Company Information
- 12.16.2 Paragon Genomics Business Overview
- 12.16.3 Paragon Genomics Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.16.4 Paragon Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.16.5 Paragon Genomics Recent Developments
- 12.17 Quintara Bio
- 12.17.1 Quintara Bio Company Information
- 12.17.2 Quintara Bio Business Overview
- 12.17.3 Quintara Bio Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.17.4 Quintara Bio Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.17.5 Quintara Bio Recent Developments
- 12.18 HyLabs
- 12.18.1 HyLabs Company Information
- 12.18.2 HyLabs Business Overview
- 12.18.3 HyLabs Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.18.4 HyLabs Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.18.5 HyLabs Recent Developments
- 12.19 MUGTC
- 12.19.1 MUGTC Company Information
- 12.19.2 MUGTC Business Overview
- 12.19.3 MUGTC Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.19.4 MUGTC Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.19.5 MUGTC Recent Developments
- 12.20 SeqCoast Genomics
- 12.20.1 SeqCoast Genomics Company Information
- 12.20.2 SeqCoast Genomics Business Overview
- 12.20.3 SeqCoast Genomics Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.20.4 SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.20.5 SeqCoast Genomics Recent Developments
- 12.21 Shanghai Baiqu Biomedical Technology
- 12.21.1 Shanghai Baiqu Biomedical Technology Company Information
- 12.21.2 Shanghai Baiqu Biomedical Technology Business Overview
- 12.21.3 Shanghai Baiqu Biomedical Technology Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.21.4 Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.21.5 Shanghai Baiqu Biomedical Technology Recent Developments
- 12.22 Illumina
- 12.22.1 Illumina Company Information
- 12.22.2 Illumina Business Overview
- 12.22.3 Illumina Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.22.4 Illumina Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.22.5 Illumina Recent Developments
- 12.23 Guangzhou IGE Biotechnology
- 12.23.1 Guangzhou IGE Biotechnology Company Information
- 12.23.2 Guangzhou IGE Biotechnology Business Overview
- 12.23.3 Guangzhou IGE Biotechnology Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.23.4 Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.23.5 Guangzhou IGE Biotechnology Recent Developments
- 12.24 IDT
- 12.24.1 IDT Company Information
- 12.24.2 IDT Business Overview
- 12.24.3 IDT Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.24.4 IDT Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.24.5 IDT Recent Developments
- 12.25 Azenta Life Sciences
- 12.25.1 Azenta Life Sciences Company Information
- 12.25.2 Azenta Life Sciences Business Overview
- 12.25.3 Azenta Life Sciences Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.25.4 Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.25.5 Azenta Life Sciences Recent Developments
- 12.26 Eurofins Genomics
- 12.26.1 Eurofins Genomics Company Information
- 12.26.2 Eurofins Genomics Business Overview
- 12.26.3 Eurofins Genomics Revenue in Targeted NGS Amplicon Sequencing Services Business (2021-2026)
- 12.26.4 Eurofins Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
- 12.26.5 Eurofins Genomics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst